HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ching-Yao Yang Selected Research

ErbB Receptors (EGF Receptor)

10/2021Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation.
1/2020Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
1/2020Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
1/2020Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort.
1/2020Successful Management of a ROS1-Rearranged Pulmonary Pleomorphic Carcinoma Using Serial Tyrosine Kinase Inhibitors.
7/2019A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor.
1/2019Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.
4/2016Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
1/2016High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
5/2014Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ching-Yao Yang Research Topics

Disease

40Neoplasms (Cancer)
01/2022 - 01/2005
9Lung Neoplasms (Lung Cancer)
10/2021 - 12/2013
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 12/2017
7Neoplasm Metastasis (Metastasis)
01/2020 - 01/2005
6Adenocarcinoma of Lung
01/2022 - 03/2006
6Wounds and Injuries (Trauma)
10/2016 - 10/2010
5Hepatocellular Carcinoma (Hepatoma)
05/2021 - 04/2005
5Adenocarcinoma
12/2020 - 01/2013
5Mitochondrial Diseases (Mitochondrial Disease)
06/2020 - 02/2011
4Critical Illness (Critically Ill)
10/2021 - 01/2014
4Carcinoma (Carcinomatosis)
12/2020 - 06/2015
4Sarcoma (Soft Tissue Sarcoma)
04/2016 - 10/2012
4Intellectual Disability (Idiocy)
12/2015 - 02/2015
4Thalassemia
12/2015 - 02/2015
3Infections
01/2021 - 05/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2020 - 09/2014
3Glucose Intolerance
09/2017 - 02/2011
3Stomach Neoplasms (Stomach Cancer)
03/2016 - 04/2008
3Autoimmune Pancreatitis
09/2015 - 09/2014
3Pain (Aches)
05/2013 - 04/2008
3Flatulence
05/2013 - 09/2008
2Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 04/2013
2Pancreatic Fistula (Pancreatic Fistulas)
01/2022 - 01/2021
2Abdominal Abscess
12/2021 - 04/2019
2Neoplasms, Cystic, Mucinous, and Serous
04/2021 - 10/2019
2Disease Progression
01/2021 - 01/2021
2Pathologic Constriction (Stenosis)
03/2019 - 06/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 04/2016
2Hyperglycemia
10/2018 - 02/2018
2Insulin Resistance
09/2017 - 11/2015
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2017 - 10/2012
2Chronic Pancreatitis
07/2015 - 09/2014
2Colorectal Neoplasms (Colorectal Cancer)
06/2013 - 01/2005
2Hemorrhage
04/2008 - 10/2005
1Hemoptysis
01/2022
1COVID-19
01/2022
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Respiratory Insufficiency (Respiratory Failure)
10/2021
1Shock
10/2021
1Fibrosis (Cirrhosis)
08/2021
1Diabetic Angiopathies (Diabetic Angiopathy)
08/2021

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
10/2021 - 05/2014
7Tyrosine Kinase InhibitorsIBA
10/2021 - 01/2019
6Insulin (Novolin)FDA Link
08/2021 - 02/2011
6Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2014
5Anaplastic Lymphoma KinaseIBA
01/2020 - 05/2014
4Messenger RNA (mRNA)IBA
01/2022 - 11/2011
4CaspasesIBA
06/2020 - 02/2011
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2014
4ParaffinIBA
03/2017 - 06/2015
3Immunosuppressive Agents (Immunosuppressants)IBA
05/2022 - 05/2009
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3B7-H1 AntigenIBA
01/2020 - 12/2017
3Caspase 3 (Caspase-3)IBA
10/2016 - 11/2011
3LigandsIBA
04/2016 - 05/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2022 - 05/2020
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2020 - 11/2011
2Matrix Metalloproteinases (MMPs)IBA
06/2020 - 11/2011
2Cytochromes c (Cytochrome c)IBA
06/2020 - 11/2011
2Gefitinib (Iressa)FDA Link
01/2020 - 01/2019
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 01/2019
2AfatinibIBA
01/2020 - 01/2019
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 01/2016
2CrizotinibIBA
01/2020 - 01/2020
2MucinsIBA
11/2019 - 10/2019
2Peptides (Polypeptides)IBA
07/2019 - 06/2005
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
07/2019 - 06/2005
2Glucose (Dextrose)FDA LinkGeneric
02/2018 - 03/2016
2Blood Glucose (Blood Sugar)IBA
09/2017 - 11/2015
2Phosphatidylinositols (Phosphatidylinositol)IBA
04/2016 - 01/2016
2ArsenicIBA
11/2015 - 02/2011
2Indicators and Reagents (Reagents)IBA
08/2015 - 05/2014
2Vascular Endothelial Growth Factor CIBA
11/2014 - 03/2006
2RNA (Ribonucleic Acid)IBA
12/2013 - 05/2009
1nasIBA
05/2022
1VaccinesIBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1durvalumabIBA
01/2022
1Streptozocin (Streptozotocin)FDA Link
08/2021
1pimagedine (aminoguanidine)IBA
08/2021
1Advanced Glycation End ProductsIBA
08/2021

Therapy/Procedure

10Therapeutics
10/2021 - 07/2007
9Immunotherapy
06/2020 - 05/2014
8Pancreaticoduodenectomy
12/2021 - 10/2005
6Kidney Transplantation
05/2022 - 05/2009
6Length of Stay
01/2022 - 09/2008
6Drug Therapy (Chemotherapy)
01/2020 - 01/2016
3Gastrectomy
03/2016 - 04/2008
3Operative Time
04/2011 - 04/2008
2Transplantation
06/2016 - 04/2011
2Nephrectomy
05/2014 - 06/2013
2Gastric Bypass (Roux-en-Y Gastric Bypass)
05/2009 - 09/2008
1Splenectomy
01/2022
1Platelet Transfusion (Blood Platelet Transfusions)
01/2022
1Molecular Targeted Therapy
10/2021
1Mechanical Ventilators (Ventilator)
10/2021
1Artificial Respiration (Mechanical Ventilation)
10/2021